ClinicalTrials.gg
Drug

Bepirovirsen clinical trials

Also written GSK3228836.

studies test it
16
open now
3
in phase 3
2
first study started
2017

How each study uses bepirovirsen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the bepirovirsen studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Oct 2026 · HIBSAGO · NDA 221276 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Bepirovirsen
11

Development codes

GSK3228836
5
ISIS 505358
1

Studies by the year they started

16 studies that test it; most in 2021 (3)

Studies that test bepirovirsen, by start year
YearStudies
20171
20202
20213
20223
20231
20242
20251
20263

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
8
Phase 3
2
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 15 · Other 1

GlaxoSmithKline (15) · National University Health System, Singapore (1)

Often tested with

Tested in the same studies.

GSK-3965193 (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test bepirovirsen.

Studies

Open first, then newest update. How each study uses bepirovirsen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 16

Given beside what is tested · 2 — bepirovirsen is usual care or a partner of the new treatment

Codes

What other systems call bepirovirsen · ClinicalTrials.gg INT018668

  • UNII (FDA) Z87O6SM01NBEPIROVIRSENOne source FDA
  • NCI Thesaurus C175748BepirovirsenOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.